Denali Therapeutics Inc (DNLI)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$17.70

Buy

$17.99

arrow-up$0.61 (+3.51%)

Prices updated at 12 Dec 2025, 21:50 EST

Prices minimum 15 mins delay

Prices in USD

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

-

CEO

Dr. Ryan J. Watts, PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

517

Head office

161 Oyster Point Boulevard

South San Francisco

United States

94080

+1 650 866-8547

contact@dnli.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Julian C. Baker Independent Director	-
Mr. Jay T. Flatley Independent Director	0.07m
Dr. Marc Tessier-Lavigne, PhD Independent Director	0.06m
Mr. Peter S. Klein Independent Director	0.07m
Dr. David P. Schenkein, M.D. Independent Director	0.07m
Mr. Steven E. Krognes, M.B.A. Director	0.05m
Dr. Ryan J. Watts, PhD Director, President and Chief Executive Officer	0.69m
Dr. Alexander O. Schuth, M.D. Secretary, Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer	0.54m
Dr. Carole Ho, M.D. Chief Medical Officer and Head of Development	0.54m
Ms. Jennifer E. Cook Independent Director	0.06m
Ms. Nancy A. Thornberry Independent Director	0.06m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock, Inc.	13,787,873
BlackRock Inc	12,289,626
Vanguard Group Inc	11,810,735
Baillie Gifford & Co Limited.	11,591,585
Wellington Management Group, LLP	10,727,450

Director dealings

Date chevron-l-regular chevron-r-regular	Action
31 Dec 2024	-
27 Dec 2024	-
27 Dec 2024	-
25 Nov 2024	-
25 Nov 2024	-
22 Nov 2024	-
22 Nov 2024	-
11 Nov 2024	-
11 Nov 2024	-
11 Nov 2024	-
11 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
01 Nov 2024	-
18 Oct 2024	-
18 Oct 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.